Targeted DOX Supramolecular Hydrogel

Dual-responsive drug release

A Pluronic F127-modified hyaluronic acid hydrogel that responds to both pH and reduction, targets SKOV-3 cancer cells, and releases doxorubicin with superior anticancer efficacy over free drug.

Li, Caixia · Qin, Zhou · Zhenzhen, Chao · Li, Liang

Arabian Journal for Science and Engineering 2025

Advantages

Exhibited more significant anticancer effects than free DOX on SKOV-3 cells

Release kinetics fitted Korsmeyer-Peppas model indicating non-Fickian diffusion